Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer - Wikidata - awgldk - TriplyDB

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

http://www.wikidata.org/entity/Q28392548

about

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy.TNF rs1799964 as a Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patients Treated With Chemoradiotherapy.Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis.Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients.Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.

P2860

Q26782962-74175E74-F30A-4A16-9652-6CF813E269EF Q36015146-397DA5D1-A544-41F7-BF47-103F1BBAF953 Q37016664-27FC3C5D-DFD4-4AED-BEB5-D0730FAAA6A5 Q37039153-9FEA04B9-C400-4203-8D7A-FF775163FAD8 Q37190172-E2B07076-F159-4B39-99C9-5E7E5E7E3BF3 Q38655709-0A644123-5C01-49CE-8429-BCC93C6EF621 Q38835268-BBC2F152-3CDE-4E18-BEC9-4B5FED0BAF42 Q38884012-D08CA1A4-A6C5-4B28-BC36-8CE563FAEAF3 Q41495258-52003BEC-6F59-471D-8082-857699470EAE

P2860

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

http://www.wikidata.org/entity/Q28392548

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@ast

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@en

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@nl

type

label

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@ast

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@en

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@nl

prefLabel

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@ast

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@en

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@nl

P1433

Q28392548-7A438740-97CD-4D3A-A833-0999EB922004

P1476

Q28392548-07047FBD-8058-4C3A-BAC9-6074E1592817

P2093

Q28392548-1DBA142A-4AC1-4A31-BF6D-D0500CF7CE11

Q28392548-2524A325-CEEE-414C-91D0-85E00B6B0D98

Q28392548-273D5C4A-8BF8-4857-9F95-FEBA1B169832

Q28392548-3D81EA9F-740C-4830-899B-E212A80CE926

Q28392548-68C24BF1-23CA-48F4-91C8-E49DBD3448F1

Q28392548-7269D580-6841-4D61-8EC8-3CCEAB889671

Q28392548-7DDD0222-9643-4CD8-A85B-5127A2C092C7

Q28392548-A4635675-95B8-45E3-88DB-9415E4D79784

Q28392548-F3306939-52D1-46A0-AB13-9BFC5641DF18

P2860

Q28392548-024A2D94-C1FE-4E20-8801-707D96E6D2BF

Q28392548-0B35FBDD-E164-47FC-A3F3-0DFC55E678C4

Q28392548-13EBA455-1771-4C4A-9D1E-45C831DBA89B

Q28392548-1D598203-E025-4C4C-8366-5400311BC3CA

Q28392548-1E03CB06-8568-4C2E-8815-240087313D75

Q28392548-270DDC2D-0500-4DBF-98F9-612D07DFDB2C

Q28392548-2C8B1CED-E7B6-4A66-B665-AD4C2B3594C6

Q28392548-2CFF910F-705D-4CD0-8BC2-D4ABCD95E7F0

Q28392548-302F7DD0-3077-40CB-BFDC-A299F017AF6C

Q28392548-34A124CB-A1C3-4117-88F4-0BE2C568E3F9

P304

Q28392548-5D13CEC9-30A5-4267-9790-91A4A43B9F6C

P31

Q28392548-001D5E2F-BE27-481D-AC37-D3A9590A2966

P356

Q28392548-881F19CF-8F78-4DE7-B86F-D6E1DBA316E7

P407

Q28392548-913D80AD-AA78-4167-9F5D-01E8870E3BCD

P433

Q28392548-F342B7AC-EAFC-46E5-8D37-BC0A69365524

P478

Q28392548-2EAD7E53-D334-4C2E-9E7E-CBB7F01FB845

P577

Q28392548-645E1D23-3E05-4D22-AC55-B7724612E803

P698

Q28392548-26BEFA33-4F49-4753-B667-DFCC9A719E06

P932

Q28392548-5B40C467-631C-4563-A815-3728D7E2340A

P356

P1433

P1476

Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer

@en

P2093

Joseph Kim

http://www.w3.org/2001/XMLSchema#string

Joyce Ho

http://www.w3.org/2001/XMLSchema#string

Julio Garcia-Aguilar

http://www.w3.org/2001/XMLSchema#string

Maithao Le

http://www.w3.org/2001/XMLSchema#string

Marjun P Duldulao

http://www.w3.org/2001/XMLSchema#string

Rebecca A Nelson

http://www.w3.org/2001/XMLSchema#string

Wendy Lee

http://www.w3.org/2001/XMLSchema#string

Wenyan Li

http://www.w3.org/2001/XMLSchema#string

Zhenbin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Conformational effects of a common codon 751 polymorphism on the C-terminal domain of the xeroderma pigmentosum D protein

Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein

A second generation human haplotype map of over 3.1 million SNPs

The International HapMap Project

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients.

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

P304

1106-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.27862

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23096768

http://www.w3.org/2001/XMLSchema#string

P932

4625921

http://www.w3.org/2001/XMLSchema#string